Document is current
Any future updates will be listed below
-
Authors
Finkelstein, Fredric O.
van Nooten, Floortje
Wiklund, Ingela
Trundell, Dylan
Cella, David
-
Funding
Funding for this research was provided by:
Astellas Pharma US
- License Information
-
More Information
Article History
Received: 6 March 2017
Accepted: 13 May 2018
First Online: 31 May 2018
Ethics approval and consent to participate
: The two trials from which data were derived for this analysis, were registered at(NCT00761657, NCT01244763), approved by all appropriate institutional review boards, conducted in accordance with the Declaration of Helsinki, and subjects provided written informed consent.
: FvN is a former employee at Astellas Pharma. IW is employed by Evidera, and DT was employed by Evidera when this study was conducted. DC and FOF received payment from Astellas for their contribution to the design and interpretation of the analyses.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
